These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 17109871
1. Content uniformity and assay requirements in current regulations. Bánfai B, Ganzler K, Kemény S. J Chromatogr A; 2007 Jul 13; 1156(1-2):206-12. PubMed ID: 17109871 [Abstract] [Full Text] [Related]
2. Probability of passing dissolution acceptance criteria for an immediate release tablet. Dumont ML, Berry MR, Nickerson B. J Pharm Biomed Anal; 2007 May 09; 44(1):79-84. PubMed ID: 17379465 [Abstract] [Full Text] [Related]
3. Content uniformity acceptance limit for a validation batch--suppositories, transdermal systems, and inhalations. Senderak ET. Drug Dev Ind Pharm; 2009 Jun 09; 35(6):735-7. PubMed ID: 19514989 [Abstract] [Full Text] [Related]
9. Parametric two-stage sequential quality assurance test of dose content uniformity. Tsong Y, Shen M. J Biopharm Stat; 2007 Jan 09; 17(1):143-57. PubMed ID: 17219760 [Abstract] [Full Text] [Related]
10. Discriminatory power of the different requirements for uniformity of dosage units in the European pharmacopoeia. Limberg J, Savsek M. Pharmeur Sci Notes; 2006 Dec 09; 2006(2):45-8. PubMed ID: 17691214 [Abstract] [Full Text] [Related]
11. Applications of NIR in early stage formulation development. Part I. Semi-quantitative blend uniformity and content uniformity analyses by reflectance NIR without calibration models. Li W, Bashai-Woldu A, Ballard J, Johnson M, Agresta M, Rasmussen H, Hu S, Cunningham J, Winstead D. Int J Pharm; 2007 Aug 01; 340(1-2):97-103. PubMed ID: 17467204 [Abstract] [Full Text] [Related]
12. Results of a market surveillance study in The Netherlands on break-mark tablets. Barends DM, Groot DW, van der Steen JC, de Kaste D, Frijlink HW. Pharmeur Sci Notes; 2006 Dec 01; 2006(2):1-7. PubMed ID: 17691208 [Abstract] [Full Text] [Related]
13. Sample sizes for batch acceptance from single- and multistage designs using two-sided normal tolerance intervals with specified content. Hauck WW, Shaikh R. J Biopharm Stat; 2001 Nov 01; 11(4):335-46. PubMed ID: 12018783 [Abstract] [Full Text] [Related]
14. Application of content uniformity test to tablet preparations. Kovács I, Hadady KK, Darbai MJ. Pharmazie; 1980 Nov 01; 35(10):609-12. PubMed ID: 6779284 [Abstract] [Full Text] [Related]
15. Design and international harmonization of pharmacopoeial standards. Calam DH. J Pharm Biomed Anal; 1995 Dec 01; 14(1-2):1-5. PubMed ID: 8833960 [Abstract] [Full Text] [Related]
16. [Exceptional Application of Content Uniformity Test and Weight Variation Test in the Japanese Pharmacopoeia 13 revision and usage of these tests for in-process tests]. Katori N, Aoyagi N, Kojima S. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997 Dec 01; (115):204-5. PubMed ID: 9641846 [Abstract] [Full Text] [Related]